Urokinase-type Plasminogen Activator (uPA) is Inhibited with QLT0267 a Small Molecule Targeting Integrin-linked Kinase (ILK)

Urokinase-type plasminogen activator (uPA) is associated with cancer recurrence where the most evidence comes from studies in breast cancer. According to the European Organization for Research and Treatment of Cancer, uPA is considered one of the most prominent biomarkers for cancer recurrence and t...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Santos, Nancy Dos, Habibi, Golareh, Wang, Michelle, Law, Jennifer H., Andrews, Heather N., Wei, Daniel, Triche, Timothy, Dedhar, Shoukat, Dunn, Sandra E.
Format: Artigo
Idioma:Inglês
Publicat: Libertas Academica 2007
Matèries:
Original Research
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3634623/
https://ncbi.nlm.nih.gov/pubmed/23645983
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars